Literature DB >> 9119097

Termination of 2nd and 3rd trimester pregnancies with mifepristone and misoprostol.

D Jannet1, N Aflak, A Abankwa, B Carbonne, L Marpeau, J Milliez.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate our use of the association of mifepristone and misoprostol for terminating second and third trimester pregnancies. STUDY
DESIGN: One hundred and six patients undergoing termination of pregnancy between January 1993 and June 1995 in our center were studied. Each patient received 600 mg of mifepristone followed 24 h later by 400 microgrammes of misoprostol every 6 h.
RESULTS: The average interval from the first administration of misoprostol to expulsion was 12.5 +/- 7.5 h (interval markedly decreased to 9.6 +/- 6.3 h in cases of intrauterine fetal death).
CONCLUSION: The efficacy of the association of mifepristone and misoprostol is comparable with that of current regimens with grealer ease of utilization and at a much lower cost.

Entities:  

Keywords:  Abortion, Induced; Biology; Clinical Research; Developed Countries; Endocrine System; Europe; Family Planning; Fertility Control, Postconception; France; Hormone Antagonists; Hormones; Mediterranean Countries; Misoprostol; Physiology; Prostaglandins; Prostaglandins, Synthetic; Research Methodology; Research Report; Ru-486; Western Europe

Mesh:

Substances:

Year:  1996        PMID: 9119097     DOI: 10.1016/s0301-2115(95)02593-6

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  4 in total

1.  Termination of pregnancy for fetal neurological abnormalities.

Authors:  Marc Dommergues
Journal:  Childs Nerv Syst       Date:  2003-08-14       Impact factor: 1.475

Review 2.  Antiprogestin pharmacodynamics, pharmacokinetics, and metabolism: implications for their long-term use.

Authors:  G R Jang; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1997-12

3.  Influence of Mifepristone in Induction Time for Terminations in the Second and Third Trimester.

Authors:  M Hoopmann; J Hirneth; J Pauluschke-Fröhlich; B Yazdi; H Abele; D Wallwiener; K O Kagan
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-03-28       Impact factor: 2.915

4.  Functioning Endocrine Tumors in Pregnancy: Diagnostic and Therapeutic Challenges.

Authors:  Kripa E Cherian; Nitin Kapoor; Thomas V Paul; Hesarghatta S Asha
Journal:  Indian J Endocrinol Metab       Date:  2021-12-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.